MedPath

Inhaled Sedation Using the Anesthetic-conserving Device ( ANACONDA) in Prehospital Emergency Medecine.

Completed
Conditions
Deep Sedation
Endotracheal Intubation
Registration Number
NCT04141267
Lead Sponsor
University Hospital, Brest
Brief Summary

Achieving the optimal sedation level for patient management is not always possible using our standard intravenous medications in Pre-hospital Emergency medicine. Inhaled sedation is possible with the Anesthetic-conserving device with a standard respirator.

The pharmacodynamics and pharmacokinetics of halogenated agents allow deep sedation quickly after absorption.

The feasibility of inhaled sedation has never been studied in hospital.

Detailed Description

Retrospecive clinical monocentric study with sedated ventilated patients with isoflurane with the AnaConda® system out of hospital.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Patient sedated by isoflurane with Anesthetic-conserving device in pre-hospital
  • Major patient
  • not opposed to participating
Exclusion Criteria
  • Adults Under legal protection
  • patient refusal to participate in study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
depth of sedationup to 1 day

depth of sedation (measured by the Ramsay Score) 10 minutes from start of the sedation and at stop of pre hospital sedation. The Ramsay score ranges level of sedation from 1(patient anxious ,agitated,restless) to 6 (patient exhibits no response).

Secondary Outcome Measures
NameTimeMethod
hemodynamic tolerance of patients during isoflurane sedationup to 1day

comparison of medium blood pressure (mmHg) before isoflurane start and 10 minutes from start of the sedation and at stop of pre hospital sedation

Trial Locations

Locations (1)

CHRU de Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath